Physician profile
Stacie L Buck
NPI 1073812251
$11,280.37
in general payments reported to CMS, 2019-2025
36 companies · $398 in 2025
The $398 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,149 · 2020: $2,371 · 2021: $942 · 2022: $702 · 2023: $713 · 2024: $2,006 · 2025: $398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,357 · Travel and Lodging: $760.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,357.07 |
| Travel and Lodging | $759.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,101.59 | 2019-2025 | Prostep, Biolox, Citrefix |
| Linvatec Corporation | $1,858.13 | 2019-2021 | |
| Medical Device Business Services, INC. | $1,132.11 | 2019 | |
| Organogenesis INC. | $834.27 | 2019-2025 | Apligraf, Puraply, Affinity |
| Smith+Nephew, INC. | $384.09 | 2019-2025 | Grafix, Stravix, Collagenase Santyl |
| Paratek Pharmaceuticals, INC. | $382.40 | 2020-2024 | Nuzyra |
| Depuy Synthes Sales INC. | $369.58 | 2019 | |
| Melinta Therapeutics, LLC | $333.86 | 2019-2023 | Orbactiv, Kimyrsa |
| Wright Medical Technology, INC. | $249.10 | 2019-2020 | |
| Horizon Therapeutics Plc | $233.37 | 2019-2023 | Krystexxa |
| Keswick Pharmaceuticals LLC | $222.18 | 2019 | |
| Hydrofera LLC | $115.72 | 2023-2024 | Hydrofera Blue, Hydrofera Blue Ready - Border |
| Averitas Pharma INC. | $112.48 | 2023-2025 | Qutenza |
| Convatec INC. | $99.83 | 2021-2024 | |
| Biocomposites INC | $94.57 | 2025 | Stimulan |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $87.40 | 2022-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Checkpoint Surgical, INC | $73.74 | 2021 | |
| Merck Sharp & Dohme LLC | $53.95 | 2019 | |
| Integra Lifesciences Corporation | $53.15 | 2019-2020 | |
| Kci USA, INC. | $47.25 | 2019-2023 | Activ.A.C., Promogran, V.A.C. Dermatac |
| Trice Medical, INC. | $45.66 | 2021 | |
| Triad Life Sciences INC. | $41.08 | 2022 | |
| Sebela Pharmaceuticals INC. | $38.40 | 2022-2023 | Pramosone, Naftin |
| Nabriva Therapeutics, Plc | $35.77 | 2021-2022 | |
| Abbott Laboratories | $34.50 | 2021-2023 | Proclaim |
| Misonix INC | $31.24 | 2020-2021 | |
| Pacira Pharmaceuticals Incorporated | $27.55 | 2021 | |
| Boston Scientific Corporation | $27.11 | 2024 | |
| Ultragenyx Pharmaceutical INC. | $26.44 | 2019-2020 | |
| Abbvie INC. | $25.66 | 2021 | |
| Kerecis Limited | $25.09 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Fortis Surgical, LLC | $19.90 | 2021 | |
| Grt US Holding, INC. | $18.84 | 2022 | |
| Next Science LLC | $17.09 | 2023 | Blastx, Xperience, Surgx |
| Advanced Oxygen Therapy INC. | $14.27 | 2024 | Topical Oxygen Chamber For Extremities |
| Arteriocyte Medical Systems, INC. | $13.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacie Buck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.